PROFIT/(LOSS) FOR THE YEAR ON DISCONTINUED OPERATIONS (Tables)

12 Months Ended

Dec. 31, 2018

Disclosure of loss on discontinued operations [Abstract]

Schedule of Loss on Remeasurement of Assets and Liabilities

The operating loss for the Cardiac point-of-care tests operation in Sweden and the profit/(loss) on remeasurement of its assets and liabilities are summarised as follows: 

	December 31, 2018 US$‘000			December 31, 2017 US$‘000			December 31, 2016 US$‘000
Revenues		—			—			—
Operating expenses		—			—			(827	)
Operating loss		—			—			(827	)
Interest expenses		—			—			(5	)
Loss from discontinued operations before tax		—			—			(832	)
Income tax credit/(expense)		—			—			186
Loss for the year		—			—			(646	)
Profit/(Loss) on remeasurement of assets and liabilities:
Property, plant and equipment (note 12)		—			—			(4,647	)
Goodwill and intangible assets (note 13)		—			—			(49,433	)
Inventories		—			—			(2,578	)
Closure costs		(22	)		1,794			(5,846	)
Foreign currency translation reserve		—			(3,080	)		(3,779	)
Tax credit/(expense)		590			(323	)		4,887
Total profit/(loss)		568			(1,609	)		(61,396	)
Profit/(Loss) for the year from discontinued operations		568			(1,609	)		(62,042	)

Schedule of Earnings Per ADS for Discontinued Operations

	December 31,2018		December 31,2017			December 31,2016
Basic earnings/(loss) per ADS (US Dollars) – discontinued operations		0.03		(0.07	)		(2.70	)
Diluted earnings/(loss per ADS (US Dollars) – discontinued operations		0.02		(0.07	)		(2.70	)
Basic earnings/(loss) per ‘A’ share (US Dollars) – discontinued operations		0.01		(0.02	)		(0.68	)
Diluted earnings/(loss) per ‘A’ share (US Dollars) – discontinued operations		0.01		(0.02	)		(0.68	)

Schedule of Cash Flows Attributable to Discontinued Operations

The cash flows attributable to discontinued operations are as follows:

	December 31,2018		December 31,2017			December 31,2016
Cash flows from operating activities		527		(2,847	)		(1,623	)
Cash flows from investing activities		-		-			(8,989	)